Sulforaphane increases the survival rate in rats with fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide

Nutrition Research - Tập 34 - Trang 982-989 - 2014
Rabab H. Sayed1, Wagdy K.B. Khalil2, Hesham A. Salem, Sanaa A. kenawy1, Bahia M. El-Sayeh1
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
2Department of Cell Biology, National Research Centre, Cairo, Egypt

Tài liệu tham khảo

Nakama, 2001, Etoposide prevents apoptosis in mouse liver with d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality, Hepatology, 33, 1441, 10.1053/jhep.2001.24561 Kim, 2008, Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice, J Pharmacol Sci, 106, 225, 10.1254/jphs.FP0071738 Galanos, 1979, Galactosamine-induced sensitization to the lethal effects of endotoxin, Proc Natl Acad Sci U S A, 76, 5939, 10.1073/pnas.76.11.5939 Silverstein, 2004, d-Galactosamine lethality model: scope and limitations, J Endotoxin Res, 10, 147 Fiuza, 2001, Human models of innate immunity: local and systemic inflammatory responses, J Endotoxin Res, 7, 385, 10.1177/09680519010070050701 Wang, 2006, Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice, Eur J Pharmacol, 534, 194, 10.1016/j.ejphar.2005.12.080 Yu, 2009, Chemopreventive agent sulforaphane enhances radiosensitivity in human tumor cells, Int J Cancer, 125, 1205, 10.1002/ijc.24480 Gan, 2010, Sulforaphane protects microcystin-LR–induced toxicity through activation of the Nrf2-mediated defensive response, Toxicol Appl Pharmacol, 247, 129, 10.1016/j.taap.2010.06.005 Greco, 2011, Sulforaphane inhibits mitochondrial permeability transition and oxidative stress, Free Radic Biol Med, 51, 2164, 10.1016/j.freeradbiomed.2011.09.017 Heiss, 2001, Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms, J Biol Chem, 276, 32008, 10.1074/jbc.M104794200 Farombi, 2006, Heme oxygenase-1 as a potential therapeutic target for hepatoprotection, J Biochem Mol Biol, 39, 479, 10.5483/BMBRep.2006.39.5.479 Sass, 2012, The multiple functions of heme oxygenase-1 in the liver, Z Gastroenterol, 50, 34, 10.1055/s-0031-1282046 Cerny, 2011, Hepatoprotective effect of curcumin in lipopolysaccharide/-galactosamine model of liver injury in rats: relationship to HO-1/CO antioxidant system, Fitoterapia, 82, 786, 10.1016/j.fitote.2011.04.003 Liu, 2012, Heme oxygenase-1 mediates the protective role of quercetin against ethanol-induced rat hepatocytes oxidative damage, Toxicol In Vitro, 26, 74, 10.1016/j.tiv.2011.10.013 Wen, 2007, Upregulation of heme oxygenase-1 with hemin prevents d-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats, Toxicology, 237, 184, 10.1016/j.tox.2007.05.014 Reeves, 1993, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J Nutr, 123, 467, 10.1093/jn/123.11.1939 Zhao, 2010, Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway, World J Gastroenterol, 16, 3002, 10.3748/wjg.v16.i24.3002 Reitman, 1957, A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases, Am J Clin Pathol, 28, 56, 10.1093/ajcp/28.1.56 Mihara, 1978, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test, Anal Biochem, 86, 271, 10.1016/0003-2697(78)90342-1 Beutler, 1963, Improved method for the determination of blood glutathione, J Lab Clin Med, 61, 882 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Wrenzycki, 1999, Alterations in the relative abundance of gene transcripts in preimplantation bovine embryos cultured in medium supplemented with either serum or PVA, Mol Reprod Dev, 53, 8, 10.1002/(SICI)1098-2795(199905)53:1<8::AID-MRD2>3.0.CO;2-K Sass, 2002, Cytokine expression in three mouse models of experimental hepatitis, Cytokine, 19, 115, 10.1006/cyto.2002.1948 Freudenberg, 1986, Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin, Infect Immun, 51, 891, 10.1128/IAI.51.3.891-895.1986 Gong, 2010, Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in d-galactosamine-sensitized mice, Int Immunopharmacol, 10, 357, 10.1016/j.intimp.2009.12.010 Tiegs, 1989, Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice, Biochem Pharmacol, 38, 627, 10.1016/0006-2952(89)90208-6 Pathil, 2011, The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFalpha-induced liver injury, J Hepatol, 54, 674, 10.1016/j.jhep.2010.07.028 Lee, 2010, Palmatine attenuates d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice, Food Chem Toxicol, 48, 222, 10.1016/j.fct.2009.10.004 Park, 2012, Protective effect of melittin on inflammation and apoptosis in acute liver failure, Apoptosis, 17, 61, 10.1007/s10495-011-0659-0 Green, 2000, Apoptosis. Gone but not forgotten, Nature, 405, 28, 10.1038/35011175 Denault, 2002, Caspases. Keys in the ignition of cell death, Chem Rev, 102, 4489, 10.1021/cr010183n Hishinuma, 1990, Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice, Hepatology, 12, 1187, 10.1002/hep.1840120518 Kuhla, 2008, Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure, Apoptosis, 13, 1427, 10.1007/s10495-008-0269-7 Xiong, 1999, Acteoside inhibits apoptosis in d-galactosamine and lipopolysaccharide-induced liver injury, Life Sci, 65, 421, 10.1016/S0024-3205(99)00263-5 Yuan, 2009, Glutathione in liver diseases and hepatotoxicity, Mol Aspects Med, 30, 29, 10.1016/j.mam.2008.08.003 Valdivia, 2009, Superoxide dismutases: a physiopharmacological update, J Physiol Biochem, 65, 195, 10.1007/BF03179070 Nakahira, 2003, Protective role of heme oxygenase-1 induction in carbon tetrachloride–induced hepatotoxicity, Biochem Pharmacol, 66, 1091, 10.1016/S0006-2952(03)00444-1 Wan, 2008, Protective effect of baicalin against lipopolysaccharide/d-galactosamine–induced liver injury in mice by up-regulation of heme oxygenase-1, Eur J Pharmacol, 587, 302, 10.1016/j.ejphar.2008.02.081 Lee, 2002, Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice, Nat Med, 8, 240, 10.1038/nm0302-240 Suttner, 1999, Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron, FASEB J, 13, 1800, 10.1096/fasebj.13.13.1800 Pahlavani, 2001, Effect of overexpression of human Cu/Zn-SOD on activation-induced lymphocyte proliferation and apoptosis, Free Radic Biol Med, 30, 1319, 10.1016/S0891-5849(01)00529-9 Gaona-Gaona, 2011, Protective effect of sulforaphane pretreatment against cisplatin-induced liver and mitochondrial oxidant damage in rats, Toxicology, 286, 20, 10.1016/j.tox.2011.04.014 Zhang, 2012, Amelioration of radiation-induced skin injury by adenovirus-mediated heme oxygenase-1 (HO-1) overexpression in rats, Radiat Oncol, 7, 4, 10.1186/1748-717X-7-4